Stockscreener 앱 받기
462.49
0.77%
-3.61
시장 영업 전:
463.86
1.37
+0.30%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals (NASDAQ:VRTX) CMO Carmen Bozic Sells 2,329 Shares - MarketBeat
Vertex Pharmaceuticals EVP and CMO Carmen Bozic Sells Shares - TradingView
Vertex (VRTX) EVP and CMO Carmen Bozic sells 2,329 shares in pre-set 10b5-1 trade - Stock Titan
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Mirabella Financial Services LLP Has $2.10 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Focus Partners Wealth Trims Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bamco Inc. NY Trims Stake in Vertex Pharmaceuticals - National Today
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Bamco Inc. NY - MarketBeat
Bank of Nova Scotia Buys 36,643 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by California Public Employees Retirement System - MarketBeat
Aquatic Capital Management LLC Acquires Shares of 29,596 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
S&P 500 Dips 0.21% as Vertex Pharmaceuticals Soars 8.31% Amid Market Struggles - Markets Mojo
Is Vertex Pharmaceuticals Heading to $600? - Yahoo Finance
Is Vertex Pharmaceuticals Heading to $600? - The Motley Fool
VRTX SEC FilingsVertex Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
The week in pharma: action, reaction and insight – week to March 13, 2026 - The Pharma Letter
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Boosts Vertex Pharmaceuticals Stake - National Today
Banco Bilbao Vizcaya Argentaria S.A. Buys 4,464 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Ameriprise Financial Inc. - MarketBeat
Aristotle Atlantic Partners LLC Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Alliancebernstein L.P. Acquires 144,266 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Wellington Management Group LLP - MarketBeat
Prosight Management LP Boosts Vertex Pharmaceuticals Stake - National Today
Prosight Management LP Takes $8.03 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Insider Sell: Duncan Mckechnie Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vertex (VRTX) EVP McKechnie sells 2,633 shares at $498.42 - Stock Titan
What Vertex Pharmaceuticals (VRTX)'s IgA Nephropathy Win Means For Its Next Major Franchise Potential - simplywall.st
Carmen Bozic proposes sale of VRTX common stock (NASDAQ: VRTX) - Stock Titan
Landscape Capital Management L.L.C. Buys 7,405 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Martingale Asset Management L P - MarketBeat
Quadrature Capital Ltd Boosts Vertex Pharmaceuticals Stake - National Today
Quadrature Capital Ltd Acquires 131,995 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Merges Strong Fundamentals with Bullish Technical Setup - ChartMill
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Certuity LLC - MarketBeat
Franklin Resources Inc. Reduces Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
2 Reasons to Watch VRTX and 1 to Stay Cautious - The Globe and Mail
2 Factors to Consider Investing in VRTX and 1 Reason to Remain Careful - Bitget
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Vertex Pharmaceuticals (VRTX) Pricing In Too Much Optimism After Recent Share Gains? - simplywall.st
Vertex Pharmaceuticals’ new kidney drug shows dramatic results in Phase 3 trial - Indian Pharma Post
Vertex Pharmaceuticals (VRTX) Sees Target Price Raised by Truist Securities | VRTX Stock News - GuruFocus
Connor Clark & Lunn Investment Management Ltd. Acquires 14,706 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
CreativeOne Wealth LLC Trims Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc - Yahoo Finance
Vertex Pharmaceuticals Shares Sold by Schroder Investment Management - National Today
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Vertex (VRTX) Moves 8.3% Higher: Will This Strength Last? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Cartesian Therapeutics (RNAC) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Schroder Investment Management Group - MarketBeat
Van ECK Associates Corp Has $58.38 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex preps FDA filing for IgAN drug after phase 3 readout - pharmaphorum
Scotiabank Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Atai Beckley N.V. (ATAI), BridgeBio Oncology Therapeutics (BBOT) - The Globe and Mail
Richard Bernstein Advisors LLC Sells 4,059 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
DE Burlo Group Inc. Sells 43,740 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Kidney Trial Success Opens Door To New Autoimmune Franchise - simplywall.st
Blair William & Co. IL Reduces Vertex Pharmaceuticals Stake - National Today
Bank of Montreal Boosts Vertex Pharmaceuticals Holdings by 15.5% - National Today
Vertex Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Bank of Montreal Can Has $164.28 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Narrow-Moat Vertex's Positive Data for Povetacicept Support Diversification Beyond Core CF Franchise - Morningstar
0.28%
0.80%
자본화:
|
볼륨(24시간):